Literature DB >> 9230047

Phosphorylation and regulation of the Na+/H+ exchanger through mitogen-activated protein kinase.

H Wang1, N L Silva, P A Lucchesi, R Haworth, K Wang, M Michalak, S Pelech, L Fliegel.   

Abstract

We examined mitogen-activated protein kinase-mediated phosphorylation and activation of the Na+/H+ exchanger isoform type 1. A rabbit skeletal muscle extract was fractionated by FPLC chromatography. Four main fractions had the ability to phosphorylate the carboxyl-terminal region of NHE1. Western blot analysis and immunoprecipitation showed that three of these were associated with MAP kinase-dependent phosphorylation. Phosphorylation studies using purified MAP kinase showed that the region involved was the carboxyl-terminal 178 amino acids of the protein and that the stoichiometry was 1 phosphate/mol of protein. In-gel kinase assays showed that cytosolic extracts from smooth muscle cells also phosphorylate the carboxyl-terminal of NHE1 and that the MAP kinase-dependent phosphorylation could be activated by PDGF and AngII. Mutant cell lines with an inducible dominant negative MAP kinase showed decreased serum activation of Na+/H+ exchange but normal hypertonic activation of the protein. The results show that MAP kinase is intimately involved in regulation of the Na+/H+ exchanger, possibly through phosphorylation of one amino acid of the carboxyl-terminal cytosolic domain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230047     DOI: 10.1021/bi970802f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

Review 1.  Functional and cellular regulation of the myocardial Na+/H+ exchanger.

Authors:  L Fliegel
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

Review 2.  Structural and functional analysis of the Na+/H+ exchanger.

Authors:  Emily R Slepkov; Jan K Rainey; Brian D Sykes; Larry Fliegel
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

3.  Sp1 and Sp3 control constitutive expression of the human NHE2 promoter by interactions with the proximal promoter and the transcription initiation site.

Authors:  Ian Pearse; Ying X Zhu; Eleanor J Murray; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

4.  Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors.

Authors:  A K Howe; S Gaillard; J S Bennett; K Rundell
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas.

Authors:  R Marches; E S Vitetta; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 6.  Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Authors:  Gerald J Maarman; Rainer Schulz; Karen Sliwa; Ralph Theo Schermuly; Sandrine Lecour
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

Review 7.  Nongenomic actions of adrenal steroids in the central nervous system.

Authors:  N K Evanson; J P Herman; R R Sakai; E G Krause
Journal:  J Neuroendocrinol       Date:  2010-03-27       Impact factor: 3.627

Review 8.  Na+-H+ exchanger-1 (NHE1) regulation in kidney proximal tubule.

Authors:  Mark D Parker; Evan J Myers; Jeffrey R Schelling
Journal:  Cell Mol Life Sci       Date:  2015-02-14       Impact factor: 9.261

9.  The sodium-hydrogen exchanger NHE1 is an Akt substrate necessary for actin filament reorganization by growth factors.

Authors:  Marcel E Meima; Bradley A Webb; H Ewa Witkowska; Diane L Barber
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

Review 10.  NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.

Authors:  Wolfgang J Linz; Andreas E Busch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-19       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.